Superior Planning, LLC’s Jazz Pharmaceuticals JAZZ Stock Holding History

Superior Planning, LLC’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$18.5K	Buy	+80	New	+$19.8K	0.01%	720

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Superior Planning, LLC's JAZZ Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 80 shares worth $18.5K. The stake represents 0.01% of the portfolio and ranks #720 among its holdings.

463 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

Superior Planning, LLC held 80 shares of Jazz Pharmaceuticals worth $18.5K as of Q3 2026.
Jazz Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Jazz Pharmaceuticals made up 0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #720 holding.
463 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.